The increased expressions of CDKN1A and GADD45 in HSCs are associated with inhibited HSCs activation and ameliorated liver fibrosis in rats treated with PPARγ agonist or histone deacetylase inhibitor 62, 63. The gene discussed is PPARG; the disease is Hepatic fibrosis.